Ashwagandha (Withania somnifera) Reverses β-Amyloid1-42 Induced Toxicity in Human Neuronal Cells: Implications in HIV-Associated Neurocognitive Disorders (HAND)

Alzheimer’s disease (AD) is characterized by progressive dysfunction of memory and higher cognitive functions with abnormal accumulation of extracellular amyloid plaques and intracellular neurofibrillary tangles throughout cortical and limbic brain regions. At present no curative treatment is available, and research focuses on drugs for slowing disease progression or providing prophylaxis. Withania somnifera (WS) also known as ‘ashwagandha’ is used widely in Ayurvedic medicine as a nerve tonic and memory enhancer. However, there is a paucity of data on the potential neuroprotective effects of W.somnifera against β-Amyloid (1–42)-induced neuropathogenesis. In the present study, we have tested the neuroprotective effects of methanol:Chloroform (3:1) extract of ashwagandha against β-amyloid induced toxicity and HIV-1Ba-L (clade B) infection using a human neuronal SK-N-MC cell line. Our results showed that β-amyloid induced cytotoxic effects in SK-N-MC cells as shown by decreased cell growth when tested individually. Also, confocal microscopic analysis showed decreased spine density, loss of spines and decreased dendrite diameter, total dendrite and spine area in clade B infected SK-N-MC cells compared to uninfected cells. However, when ashwagandha was added to β-amyloid treated and HIV-1 infected samples, the toxic effects were neutralized. Further, the MTT cell viability assays and the peroxisome proliferator-activated receptor-γ (PPARγ) levels supported these observations indicating the neuroprotective effect of WS root extract against β-amyloid and HIV-1Ba-L (clade B) induced neuro-pathogenesis.

• Publication year

  2013

• Venue

  PLoS ONE

• Publication date

  2013-10-16

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1371/journal.pone.0077624PMID 24147038PMCID 3797707
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Alzheimer's disease risk gene CD33 inhibits microglial uptake of amyloid beta.

  2013cited by this paper
• Human Synaptic Plasticity Gene Expression Profile and Dendritic Spine Density Changes in HIV-Infected Human CNS Cells: Role in HIV-Associated Neurocognitive Disorders (HAND)

  2013cited by this paper
• Chemopreventive potential of an ethyl acetate fraction from Curcuma longa is associated with upregulation of p57(kip2) and Rad9 in the PC-3M prostate cancer cell line.

  2012cited by this paper
• Mechanisms Underlying the Rapid Peroxisome Proliferator-Activated Receptor-γ-Mediated Amyloid Clearance and Reversal of Cognitive Deficits in a Murine Model of Alzheimer's Disease

  2012cited by this paper
• Combinatorial cytotoxic effects of Curcuma longa and Zingiber officinale on the PC-3M prostate cancer cell line

  2012cited by this paper
• Progressive and unconventional pharmacotherapeutic approaches to Alzheimer's disease therapy.

  2012cited by this paper
• Withania somnifera reverses Alzheimer's disease pathology by enhancing low-density lipoprotein receptor-related protein in liver

  2012cited by this paper
• Intraneuronal Aβ accumulation and neurodegeneration: lessons from transgenic models.

  2012cited by this paper
• Cerebral &bgr;-amyloid deposition predicts HIV-associated neurocognitive disorders in APOE &egr;4 carriers

  2012cited by this paper
• Natural Modulators of Amyloid-Beta Precursor Protein Processing.

  2012cited by this paper
• Aβ Internalization by Neurons and Glia

  2011cited by this paper
• Functional activity of the novel Alzheimer's amyloid β-peptide interacting domain (AβID) in the APP and BACE1 promoter sequences and implications in activating apoptotic genes and in amyloidogenesis.

  2011cited by this paper
• Antiretroviral medications disrupt microglial phagocytosis of β-amyloid and increase its production by neurons: Implications for HIV-associated neurocognitive disorders

  2011cited by this paper
• Human Atherosclerotic Plaque Alternative Macrophages Display Low Cholesterol Handling but High Phagocytosis Because of Distinct Activities of the PPAR&ggr; and LXR&agr; Pathways

  2011cited by this paper
• Natural products as a source of Alzheimer's drug leads.

  2011cited by this paper
• Control of macrophage activation and function by PPARs.

  2010cited by this paper
• In vitro protective effects of Withania somnifera (L.) dunal root extract against hydrogen peroxide and β‐amyloid(1–42)‐induced cytotoxicity in differentiated PC12 cells

  2010cited by this paper
• Microglia and inflammation in Alzheimer's disease.

  2010cited by this paper
• Alzheimer's disease: strategies for disease modification

  2010cited by this paper
• The genetics of Alzheimer disease: back to the future.

  2010cited by this paper
• Neuroprotective Effects of Withania somnifera Dunal.: A Possible Mechanism

  2009cited by this paper
• Reversal of long-term dendritic spine alterations in Alzheimer disease models

  2009cited by this paper
• Withania somnifera: an Indian ginseng.

  2008cited by this paper
• Current and future therapy in Alzheimer’s disease

  2008cited by this paper
• Intracellular amyloid beta-protein as a therapeutic target for treating Alzheimer's disease.

  2008cited by this paper
• Exploring the full spectrum of macrophage activation

  2008cited by this paper
• Multipotent natural agents to combat Alzheimer's disease. Functional spectrum and structural features

  2008cited by this paper
• Screening of selected Indian medicinal plants for acetylcholinesterase inhibitory activity.

  2007cited by this paper
• Natural products as sources of new drugs over the last 25 years.

  2007cited by this paper
• The neuroprotective effect of Withania somnifera root extract in MPTP-intoxicated mice: An analysis of behavioral and biochemical varibles

  2007cited by this paper
• Different Conformations of Amyloid β Induce Neurotoxicity by Distinct Mechanisms in Human Cortical Neurons

  2006cited by this paper
• A hundred years of Alzheimer's disease research.

  2006cited by this paper
• Position statement of the American Association for Geriatric Psychiatry regarding principles of care for patients with dementia resulting from Alzheimer disease.

  2006cited by this paper
• Intracellular amyloid beta-protein and its associated molecules in the pathogenesis of Alzheimer's disease.

  2006cited by this paper
• Role of genes and environments for explaining Alzheimer disease.

  2006cited by this paper
• Matrix Metalloproteinase-9 Degrades Amyloid-β Fibrils in Vitro and Compact Plaques in Situ*

  2006cited by this paper
• Neuroprotective effects of Withania somnifera on 6-hydroxydopamine induced Parkinsonism in rats

  2005cited by this paper
• The role of cerebral amyloid beta accumulation in common forms of Alzheimer disease.

  2005cited by this paper
• The role of cerebral amyloid β accumulation in common forms of Alzheimer disease

  2005cited by this paper
• Neuritic regeneration and synaptic reconstruction induced by withanolide A

  2005cited by this paper
• Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective.

  2005cited by this paper
• Intracellular Aβ42 activates p53 promoter: a pathway to neurodegeneration in Alzheimer's disease

  2005cited by this paper
• Nucleation-Dependent Polymerization Is an Essential Component of Amyloid-Mediated Neuronal Cell Death

  2005cited by this paper
• Intracellular Abeta42 activates p53 promoter: a pathway to neurodegeneration in Alzheimer's disease.

  2005cited by this paper
• Natural Products and Derivatives Affecting Neurotransmission Relevant to Alzheimer’s and Parkinson’s Disease

  2005cited by this paper
• β-Amyloid-Induced Neurodegeneration and Protection by Structurally Diverse Microtubule-Stabilizing Agents

  2005cited by this paper
• ReviewTwenty Years of the Alzheimer ’ s Disease Amyloid Hypothesis : A Genetic Perspective

  2005cited by this paper
• Brain deposition of beta-amyloid is a common pathologic feature in HIV positive patients

  2005cited by this paper
• Strategies for disease modification in Alzheimer's disease

  2004cited by this paper
• Toxicity of amyloid beta peptide: tales of calcium, mitochondria, and oxidative stress.

  2004cited by this paper
• Toxicity of Amyloid β Peptide: Tales of Calcium, Mitochondria, and Oxidative Stress

  2004cited by this paper
• Protein aggregation and neurodegenerative disease

  2004cited by this paper
• Alternative activation of macrophages

  2003cited by this paper
• Withanolide derivatives from the roots of Withania somnifera and their neurite outgrowth activities.

  2002cited by this paper
• Anti-oxidant effect of Withania somnifera glycowithanolides in chronic footshock stress-induced perturbations of oxidative free radical scavenging enzymes and lipid peroxidation in rat frontal cortex and striatum.

  2001cited by this paper
• Degradation of the Alzheimer's Amyloid β Peptide by Endothelin-converting Enzyme*

  2001cited by this paper
• Angiotensin-converting Enzyme Degrades Alzheimer Amyloid β-Peptide (Aβ); Retards Aβ Aggregation, Deposition, Fibril Formation; and Inhibits Cytotoxicity*

  2001cited by this paper
• Neprilysin Degrades Both Amyloid β Peptides 1–40 and 1–42 Most Rapidly and Efficiently among Thiorphan- and Phosphoramidon-sensitive Endopeptidases*

  2001cited by this paper
• Neuroprotective Effects of Withania somnifera Dunn. in Hippocampal Sub‐regions of Female Albino Rat

  2001cited by this paper
• Scientific basis for the therapeutic use of Withania somnifera (ashwagandha): a review.

  2000cited by this paper
• Review on some plants of Indian traditional medicine with antioxidant activity.

  2000cited by this paper
• Dendrite extension by methanol extract of Ashwagandha (roots of Withania somnifera) in SK‐N‐SH cells

  2000cited by this paper
• Plasmin cleavage of the amyloid beta-protein: alteration of secondary structure and stimulation of tissue plasminogen activator activity.

  1999cited by this paper
• Antistressor effect of Withania somnifera.

  1999cited by this paper
• Prevalence of Alzheimer plaques in AIDS

  1998cited by this paper
• Systemic administration of defined extracts from Withania somnifera (Indian Ginseng) and Shilajit differentially affects cholinergic but not glutamatergic and GABAergic markers in rat brain.

  1997cited by this paper
• Amyloid β-protein toxicity and oxidative stress in Alzheimer’s disease

  1997cited by this paper
• Amyloid beta-protein toxicity and oxidative stress in Alzheimer's disease.

  1997cited by this paper
• Neurocytopathic effects of beta-amyloid-stimulated monocytes: a potential mechanism for central nervous system damage in Alzheimer disease.

  1996influential reference
• Superoxide dismutase delays neuronal apoptosis: a role for reactive oxygen species in programmed neuronal death.

  1995cited by this paper
• The toxicity in vitro of beta-amyloid protein.

  1995cited by this paper
• A comparative pharmacological investigation of Ashwagandha and Ginseng.

  1994cited by this paper
• Inhibition of PC12 cell redox activity is a specific, early indicator of the mechanism of beta-amyloid-mediated cell death.

  1994cited by this paper
• Hydrogen peroxide mediates amyloid beta protein toxicity.

  1994cited by this paper
• Dose-response effects of malachite green on free radical formation, lipid peroxidation and DNA damage in Syrian hamster embryo cells and their modulation by antioxidants.

  1994cited by this paper
• Apoptosis is induced by beta-amyloid in cultured central nervous system neurons.

  1993cited by this paper
• Vitamin E protects nerve cells from amyloid βprotein toxicity

  1992cited by this paper
• Vitamin E protects nerve cells from amyloid beta protein toxicity.

  1992cited by this paper
• The cytotoxic properties of malachite green are associated with the increased demethylase, aryl hydrocarbon hydroxylase and lipid peroxidation in primary cultures of Syrian hamster embryo cells.

  1992cited by this paper
• β-Amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage

  1990cited by this paper
• Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides.

  1990cited by this paper

• Ashwagandha (Withania Somnifera): a comprehensive narrative review of its role in enhancing physical performance and health.

  2026cites this paper
• Decoding natural products for neuroprotection: Pathway networks and structural insights for drug development

  2025cites this paper
• Effect of ashwagandha (Withania somnifera) extract with Sominone (Somin-On™) to improve memory in adults with mild cognitive impairment: A randomized, double-blind, placebo-controlled study

  2025cites this paper
• Effect of Withania somnifera on Expression of Selected Genes in Hippocampus of Male Wistar Rats Subjected to Chronic Unpredictable Mild Stress

  2025cites this paper
• The pathophysiological signaling and efficacy of medicinal herbal compounds in Alzheimer’s disease

  2025cites this paper
• Molecular and therapeutic insights into Withania somnifera (Ashwagandha) for cognition and neuroprotection

  2025cites this paper
• Investigating the Synergistic Neuroprotective Effects of Plant-Derived Antioxidants and the Psychedelic N,N-Dimethyltryptamine in Alzheimer’s Disease Therapy

  2025cites this paper
• Whole-genome sequencing shows modulation of neurodegenerative genes by Withania somnifera in human SK-N-SH cells

  2025cites this paper
• Safety of 12-Months Administration of Ashwagandha (Withania somnifera) Standardized Root Extract in Healthy Adults: A Prospective, Observational Study.

  2025cites this paper
• Neuroprotective and cognitive-enhancing potentials of herbal remedies: Focus on St. John's wort, green tea, and Ashwagandha.

  2025cites this paper
• Withania somnifera showed neuroprotective effect and increased longevity in Drosophila Alzheimer’s disease model

  2024cites this paper
• Unveiling the impact of Aging on BBB and Alzheimer's disease: Factors and Therapeutic implications.

  2024cites this paper
• Antiviral Activity of Withanolide A Against Different Infectivity Phases of Dengue Virus Serotype 2 in Vero Cell Line

  2024cites this paper
• Characteristics and Pleiotropic Effects of Ashwagandha – A Literature Review

  2024cites this paper
• Safety and Efficacy of Ashwagandha Root Extract on Cognition, Energy and Mood Problems in Adults: Prospective, Randomized, Placebo-Controlled Study

  2024influential citation
• A critical review on the active anti-viral metabolites of bioprospecting traditionally used plant species from semi-arid regions of the subcontinent

  2024cites this paper
• Withania somnifera (Ashwagandha) Improves Spatial Memory, Anxiety and Depressive-like Behavior in the 5xFAD Mouse Model of Alzheimer’s Disease

  2024cites this paper
• A critical appraisal on the involvement of plant-based extracts as neuroprotective agents (2012–2022): an effort to ease out decision-making process for researchers

  2024cites this paper
• Acute and Repeated Ashwagandha Supplementation Improves Markers of Cognitive Function and Mood

  2024cites this paper
• Withania somnifera (L.) Dunal, a Potential Source of Phytochemicals for Treating Neurodegenerative Diseases: A Systematic Review

  2024cites this paper
• Enhancement of hippocampal-dependent spatial memory by Ashwagandha (Withania somnifera) characterized by activation of NMDA receptors against monosodium glutamate-induced neurotoxicity in rats

  2023cites this paper
• Ashwagandha (Withania somnifera)—Current Research on the Health-Promoting Activities: A Narrative Review

  2023cites this paper
• Clinical pharmacokinetic evaluation of Withania somnifera (L.) Dunal root extract in healthy human volunteers: A non-randomized, single dose study utilizing UHPLC-MS/MS analysis.

  2023cites this paper
• Structure-Based Identification of Natural-Product-Derived Compounds with Potential to Inhibit HIV-1 Entry

  2023cites this paper
• Management of neuromyelitis optica through Ayurveda- A case report

  2023cites this paper
• Clinical safety and tolerability evaluation of Withania somnifera (L.) Dunal (Ashwagandha) root extract in healthy human volunteers

  2023cites this paper
• Withania somnifera (L.) Dunal (Ashwagandha); current understanding and future prospect as a potential drug candidate

  2022cites this paper
• Sodium–calcium exchanger isoform-3 targeted Withania somnifera (L.) Dunal therapeutic intervention ameliorates cognition in the 5xFAD mouse model of Alzheimer’s disease

  2022cites this paper
• Genomics as a Clinical Decision Support Tool for Identifying and Addressing Modifiable Causes of Cognitive Decline and Improving Outcomes: Proof of Concept Support for This Personalized Medicine Strategy

  2022cites this paper
• Potential clinical applications of Ashwagandha (Withania somnifera) in medicine and neuropsychiatry

  2022cites this paper
• The Antioxidative Effects of Picein and Its Neuroprotective Potential: A Review of the Literature

  2022cites this paper
• Withania somnifera

  2021cites this paper
• Key Rasayana Plants of Ayurveda

  2021cites this paper
• Withania somnifera (L.) Dunal (Ashwagandha): A comprehensive review on ethnopharmacology, pharmacotherapeutics, biomedicinal and toxicological aspects.

  2021cites this paper
• Dietary Phytochemicals: As a Natural Source of Antioxidants

  2021cites this paper
• Neuroactive herbal agents for cognitive dysfunction

  2021cites this paper
• Experimental evidence and mechanism of action of some popular neuro-nutraceutical herbs

  2021cites this paper
• Network pharmacology of Withania somnifera against stress associated neurodegenerative diseases

  2021cites this paper
• Development of Synergy-Based Combination for Learning and Memory Using in vitro, in vivo and TLC-MS-Bioautographic Studies

  2021cites this paper
• Role of Phytomolecules on the Basic Biology of Aging

  2021cites this paper
• A Wonder Plant Withania: Pharmacological and Chemical Perspectives

  2021cites this paper
• A double-blind, randomized, placebo-controlled trial on the effect of Ashwagandha (Withania somnifera Dunal.) root extract in improving cardiorespiratory endurance and recovery in healthy athletic adults.

  2021cites this paper
• Network pharmacology of Withania somnifera against stress associated neurodegenerative diseases

  2021cites this paper
• Investigation of CYP2B6, 3A4 and β-esterase interactions of Withania somnifera (L.) Dunal in human liver microsomes and HepG2 cells.

  2021cites this paper
• Could nature be the solution- A review on selected folklore medicinal plants with antiviral activities repurposed for COVID-19 treatment

  2021cites this paper
• Withania somnifera showed neuroprotective effect and increase longevity in Drosophila Alzheimer’s disease model

  2020cites this paper
• Natural products as anti-Alzheimer's drugs

  2020cites this paper
• Ashwagandha in brain disorders: A review of recent developments.

  2020cites this paper
• Neurodegenerative diseases and Withania somnifera (L.): An update.

  2020cites this paper
• Pharmacological evaluation of Ashwagandha highlighting its healthcare claims, safety, and toxicity aspects

  2020influential citation
• Implications of phytochemicals as disease-modifying agents against Huntington's disease (HD): Bioactivity, animal models and transgenics, synergism and structure–activity studies

  2020cites this paper
• Neuroprotective Effect of CR-777, a Glutathione Derivative of Withaferin A, Obtained through the Bioconversion of Withania somnifera (L.) Dunal Extract by the Fungus Beauveria bassiana

  2019cites this paper
• Withania somnifera (L.) Dunal: An Overview of Bioactive Molecules, Medicinal Properties and Enhancement of Bioactive Molecules Through Breeding Strategies

  2019cites this paper
• Evidence of a PPAR&ggr;‐mediated mechanism in the ability of Withania somnifera to attenuate tolerance to the antinociceptive effects of morphine

  2019cites this paper
• Ethnomedicinal uses of the local flora in Chenab riverine area, Punjab province Pakistan

  2019cites this paper
• Withania somnifera (L.) Dunal ameliorates neurodegeneration and cognitive impairments associated with systemic inflammation

  2019cites this paper
• M1 muscarinic receptor is a key target of neuroprotection, neuroregeneration and memory recovery by i-Extract from Withania somnifera

  2019cites this paper
• Withanolide a penetrates brain via intra-nasal administration and exerts neuroprotection in cerebral ischemia reperfusion injury in mice

  2019cites this paper
• Role of Withaferin A as a Neuroprotectant against Beta Amyloid Induced Toxicity and associated mechanism

  2019cites this paper
• "APP"reciating the complexity of HIV-induced neurodegenerative diseases

  2018cites this paper
• Nootropic and Anti-Alzheimer’s Actions of Medicinal Plants: Molecular Insight into Therapeutic Potential to Alleviate Alzheimer’s Neuropathology

  2018cites this paper
• Withanolide production by fungal endophyte isolated from Withania somnifera

  2018cites this paper
• Withaferin A Suppresses Beta Amyloid in APP Expressing Cells: Studies for Tat and Cocaine Associated Neurological Dysfunctions

  2018cites this paper
• Pharmacokinetic Herb-Drug Interactions involving african traditional medicines - fingerprint analysis and in vitro metabolism studies

  2018cites this paper
• Indian Ginseng (Withania somnifera) supplementation ameliorates oxidative stress and mitochondrial dysfunctions in experimental model of stroke

  2018cites this paper
• Potential Therapeutic Use of Withania somnifera for Treatment of Amyotrophic Lateral Sclerosis

  2017cites this paper
• Common gene-network signature of different neurological disorders and their potential implications to neuroAIDS

  2017cites this paper
• HIV-1 counteracts an innate restriction by amyloid precursor protein resulting in neurodegeneration

  2017cites this paper
• Viwithan, a Standardized Withania somnifera Root Extract Induces Apoptosis in Murine Melanoma Cells

  2017cites this paper
• Efficacy and Safety of Ashwagandha (Withania somnifera (L.) Dunal) Root Extract in Improving Memory and Cognitive Functions

  2017cites this paper
• Overview and Current Status of Alzheimer’s Disease in Bangladesh

  2017cites this paper
• HIV-1 and cocaine disrupt dopamine reuptake and medium spiny neurons in female rat striatum

  2017cites this paper
• Human Immunodeficiency Virus and Herbal Medicine

  2017cites this paper
• Herbal Drugs: A New Hope for Huntington's Disease

  2017cites this paper
• Ashwagandha for Brain Health: Experimental Evidence for Its Neuroregenerative Activities

  2017cites this paper
• Using Human Neural Stem Cells as a Model to Understand the “Science of Ashwagandha”

  2017cites this paper
• Withania somnifera: Ethnobotany, Pharmacology, and Therapeutic Functions

  2017cites this paper
• Cellular and Molecular Targets Underpinning Memory Enhancement by Ashwagandha

  2017cites this paper
• Natural Products against Huntington's Disease (HD): Implications of Neurotoxic Animal Models and Transgenics in Preclinical Studies

  2017cites this paper
• Ashwagandha and Its Active Ingredient, Withanolide A, Increase Activation of the Phosphatidylinositol 3’ Kinase/Akt Cascade in Hippocampal Neurons

  2017cites this paper
• Neuroprotective Potential of Withania somnifera (Ashwagandha) in Neurological Conditions

  2017cites this paper
• The Potential Utility of Ashwagandha for Improving Cognitive Dysfunction in Persons with Bipolar or Other Neurocognitive Disorders

  2017cites this paper
• Natural products against Alzheimer's disease: Pharmaco-therapeutics and biotechnological interventions.

  2017cites this paper
• Effect of Cocaine on HIV Infection and Inflammasome Gene Expression Profile in HIV Infected Macrophages

  2016cites this paper
• Neuropharmacological Properties of Withania somnifera - Indian Ginseng: An Overview on Experimental Evidence with Emphasis on Clinical Trials and Patents.

  2016cites this paper
• Nootropic potential of Ashwagandha leaves: Beyond traditional root extracts.

  2016cites this paper
• A dual brain-targeting curcumin-loaded polymersomes ameliorated cognitive dysfunction in intrahippocampal amyloid-β1–42-injected mice

  2016cites this paper
• Withania somnifera and Its Withanolides Attenuate Oxidative and Inflammatory Responses and Up-Regulate Antioxidant Responses in BV-2 Microglial Cells

  2016cites this paper
• Development of TIMP1 magnetic nanoformulation for regulation of synaptic plasticity in HIV-1 infection

  2016cites this paper
• Natural Products as Anti-HIV Agents and Role in HIV-Associated Neurocognitive Disorders (HAND): A Brief Overview

  2016cites this paper
• Arctigenin Treatment Protects against Brain Damage through an Anti-Inflammatory and Anti-Apoptotic Mechanism after Needle Insertion

  2016cites this paper
• Withanolide A offers neuroprotection, ameliorates stress resistance and prolongs the life expectancy of Caenorhabditis elegans.

  2016cites this paper
• Development of TIMP 1 magnetic nanoformulation for regulation of synaptic plasticity in hIV-1 infection

  2016cites this paper
• Lower CSF Aβ is Associated with HAND in HIV-Infected Adults with a Family History of Dementia.

  2016cites this paper
• Natural Withanolides in the Treatment of Chronic Diseases

  2016cites this paper
• Reducing Aβ load and tau phosphorylation: Emerging perspective for treating Alzheimer's disease.

  2015cites this paper
• HIV-1 Tat and cocaine mediated synaptopathy in cortical and midbrain neurons is prevented by the isoflavone Equol

  2015cites this paper
• Neuroprotective therapeutics from botanicals and phytochemicals against Huntington's disease and related neurodegenerative disorders

  2015cites this paper
• Therapeutical Neurotargeting via Magnetic Nanocarrier: Implications to Opiate-Induced Neuropathogenesis and NeuroAIDS.

  2015cites this paper
• Anti-inflammatory, antioxidant and anti-acetylcholinesterase activities of Bouvardia ternifolia: potential implications in Alzheimer’s disease

  2015cites this paper